These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 16049032)

  • 1. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.
    Frisdal E; Klerkx AH; Le Goff W; Tanck MW; Lagarde JP; Jukema JW; Kastelein JJ; Chapman MJ; Guerin M
    Hum Mol Genet; 2005 Sep; 14(18):2607-18. PubMed ID: 16049032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.
    Le Goff W; Guerin M; Nicaud V; Dachet C; Luc G; Arveiler D; Ruidavets JB; Evans A; Kee F; Morrison C; Chapman MJ; Thillet J
    Atherosclerosis; 2002 Apr; 161(2):269-79. PubMed ID: 11888509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
    Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.
    Dullaart RP; Borggreve SE; Hillege HL; Dallinga-Thie GM
    Scand J Clin Lab Invest; 2008; 68(2):99-105. PubMed ID: 17852818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P; Mensink RP; Hornstra G
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism.
    Lu H; Inazu A; Moriyama Y; Higashikata T; Kawashiri MA; Yu W; Huang Z; Okamura T; Mabuchi H
    J Mol Med (Berl); 2003 Apr; 81(4):246-55. PubMed ID: 12700892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
    de Grooth GJ; Zerba KE; Huang SP; Tsuchihashi Z; Kirchgessner T; Belder R; Vishnupad P; Hu B; Klerkx AH; Zwinderman AH; Jukema JW; Sacks FM; Kastelein JJ; Kuivenhoven JA
    J Am Coll Cardiol; 2004 Mar; 43(5):854-7. PubMed ID: 14998629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C-->A polymorphism and a novel promoter variant are independently associated with CETP concentration.
    Klerkx AH; Tanck MW; Kastelein JJ; Molhuizen HO; Jukema JW; Zwinderman AH; Kuivenhoven JA
    Hum Mol Genet; 2003 Jan; 12(2):111-23. PubMed ID: 12499392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction.
    Corbex M; Poirier O; Fumeron F; Betoulle D; Evans A; Ruidavets JB; Arveiler D; Luc G; Tiret L; Cambien F
    Genet Epidemiol; 2000 Jul; 19(1):64-80. PubMed ID: 10861897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hepatic lipase gene promoter nucleotide variations on serum HDL cholesterol concentration in the general Japanese population.
    Inazu A; Nishimura Y; Terada Y; Mabuchi H
    J Hum Genet; 2001; 46(4):172-7. PubMed ID: 11322655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients.
    Yilmaz H; Isbir T; Agachan B; Karaali ZE
    Cell Biochem Funct; 2005; 23(1):23-8. PubMed ID: 15386541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
    Boekholdt SM; Sacks FM; Jukema JW; Shepherd J; Freeman DJ; McMahon AD; Cambien F; Nicaud V; de Grooth GJ; Talmud PJ; Humphries SE; Miller GJ; Eiriksdottir G; Gudnason V; Kauma H; Kakko S; Savolainen MJ; Arca M; Montali A; Liu S; Lanz HJ; Zwinderman AH; Kuivenhoven JA; Kastelein JJ
    Circulation; 2005 Jan; 111(3):278-87. PubMed ID: 15655129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variants of Cholesteryl ester transfer protein gene and their association with lipid parameters in healthy volunteers of Tamilian population.
    Padmaja N; Ravindra Kumar M; Soya SS; Adithan C
    Clin Chim Acta; 2007 Jan; 375(1-2):140-6. PubMed ID: 16890925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF; Muhlestein JB; Horne BD; Hart NI; Bair TL; Molhuizen HO; Anderson JL
    Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks.
    Hodoğlugil U; Williamson DW; Huang Y; Mahley RW
    Clin Genet; 2005 Aug; 68(2):118-27. PubMed ID: 15996208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Bakker SJ; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4198-204. PubMed ID: 15840744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cholesteryl ester transfer protein gene polymorphisms and variations in lipid levels in patients with coronary heart disease.
    Zheng KQ; Zhang SZ; He Y; Zhang L; Zhang KL; Huang DJ; Sun Y
    Chin Med J (Engl); 2004 Sep; 117(9):1288-92. PubMed ID: 15377415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease.
    Horne BD; Camp NJ; Anderson JL; Mower CP; Clarke JL; Kolek MJ; Carlquist JF;
    J Am Coll Cardiol; 2007 May; 49(20):2053-60. PubMed ID: 17512363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.